6201. Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry.
作者: Ryan P Barbaro.;Graeme MacLaren.;Philip S Boonstra.;Alain Combes.;Cara Agerstrand.;Gail Annich.;Rodrigo Diaz.;Eddy Fan.;Katarzyna Hryniewicz.;Roberto Lorusso.;Matthew L Paden.;Christine M Stead.;Justyna Swol.;Theodore J Iwashyna.;Arthur S Slutsky.;Daniel Brodie.; .
来源: Lancet. 2021年398卷10307期1230-1238页
Over the course of the COVID-19 pandemic, the care of patients with COVID-19 has changed and the use of extracorporeal membrane oxygenation (ECMO) has increased. We aimed to examine patient selection, treatments, outcomes, and ECMO centre characteristics over the course of the pandemic to date.
6205. Functioning of the International Health Regulations during the COVID-19 pandemic.
作者: Preben Aavitsland.;Ximena Aguilera.;Seif Salem Al-Abri.;Vincent Amani.;Carmen C Aramburu.;Thouraya A Attia.;Lucille H Blumberg.;Malinee Chittaganpitch.;James W Le Duc.;Dexin Li.;Talat Mokhtariazad.;Mohamed Moussif.;Olubunmi E Ojo.;Jean-Marie Okwo-Bele.;Tomoya Saito.;Amadou Alpha Sall.;Mark W A P Salter.;Myongsei Sohn.;Lothar H Wieler.
来源: Lancet. 2021年398卷10308期1283-1287页 6206. Diagnosing acute intestinal graft-versus-host disease by a non-invasive method: transabdominal ultrasonography and colour doppler imaging.
作者: Manuela Spadea.;Francesco Saglio.;Rosanna Pessolano.;Anna Opramolla.;Pier Luigi Calvo.;Franca Fagioli.
来源: Lancet. 2021年398卷10306期1170页 6220. Head and neck cancer.
作者: Mayur D Mody.;James W Rocco.;Sue S Yom.;Robert I Haddad.;Nabil F Saba.
来源: Lancet. 2021年398卷10318期2289-2299页
Head and neck cancer is the seventh most common type of cancer worldwide and comprise of a diverse group of tumours affecting the upper aerodigestive tract. Although many different histologies exist, the most common is squamous cell carcinoma. Predominant risk factors include tobacco use, alcohol abuse, and oncogenic viruses, including human papillomavirus and Epstein-Barr virus. Head and neck malignancies remain challenging to treat, requiring a multidisciplinary approach, with surgery, radiotherapy, and systemic therapy serving as key components of the treatment of locally advanced disease. Although many treatment principles overlap, treatment is generally site-specific and histology-specific. This Seminar outlines the current understanding of head and neck cancer and focuses on treatment principles, while also discussing future directions to improve the outcomes of patients with these malignancies.
|